Bumetanide 1 MG Oral Tablet

INDICATIONS AND USAGE Bumetanide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route. Successful treatment with bumetanide tablets following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity.

American Health Packaging

FDA Reported Adverse Reactions
`[1] fatigue` `[2] dyspnoea` `[3] off label use` `[4] drug ineffective` `[5] nausea` `[6] pain` `[7] headache` `[8] diarrhoea` `[9] arthralgia` `[10] pyrexia`

5 years ago

OVAL YELLOW BUMEX 1

5 years ago

BUMEX 1 OVAL YELLOW

HOW SUPPLIED

BUMEtanIDE Tablets USP, for oral administration, are available as: 1 mg: yellow colored, elliptical, flat-face, beveled edged tablets, engraved "BUMEX 1" on one side, and supplied as: Unit dose packages of 50 (5 x 10) NDC 60687-384-65 Unit dose packages of 100 (10 x 10) NDC 60687-384-01 2 mg: peach colored, elliptical, flat-face, beveled edged tablets, engraved “BUMEX 2” on one side, and supplied as: Unit dose packages of 50 (5 x 10) NDC 60687-535-65 Store at 68° to 77°F (20° to 25°C); excursions permitted between 59° to 86°F (15° to 30°C) (see USP Controlled Room Temperature). FOR YOUR PROTECTION: Do not use if blister is torn or broken. Product of Italy

More pills like OVAL BUMEX 1

Related Pills

bumetanide 2 MG Oral Tablet

American Health Packaging

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site